Notice: This company has been marked as potentially delisted and may not be actively trading. Keryx Biopharmaceuticals (KERX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period LBTI Lithium & Boron Technology, Inc.September 24, 2024 | seekingalpha.com2024 Biopharmaceutical Industry LandscapeAugust 17, 2024 | morningstar.comCaliway Biopharmaceuticals Co Ltd 6919April 13, 2024 | morningstar.comXTL Biopharmaceuticals Ltd ADR XTLBNovember 15, 2023 | morningstar.comImmuneOnco Biopharmaceuticals Shanghai Inc (1541)September 11, 2023 | investing.comQ2 2023 Westrock Coffee Co Earnings CallAugust 13, 2023 | finance.yahoo.comKeryx CEO vs. a Short-Seller: Zerenex Patent DebateJuly 29, 2023 | thestreet.com8-K: CUTERA INCMay 12, 2023 | marketwatch.comManoj MadhavanMay 6, 2023 | seekingalpha.comBiopharmaceuticals Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand and ForecastMay 3, 2023 | finance.yahoo.comStaidson (Beijing) Biopharmaceuticals Co. Ltd.April 13, 2023 | wsj.comBiopharmaceuticals Market Growth: Worth $700Bn by 2028 Led by Monoclonal Antibodies Held Market Share of 48.42% in 2022 | The Insight PartnersMarch 28, 2023 | finance.yahoo.comBiopharmaceuticals Market 2023 Analysis by Market Size, New Technology, Growth Rate, Geographical Regions, Drivers and Outlook to 2027January 29, 2023 | marketwatch.comNAVB Navidea Biopharmaceuticals, Inc.January 25, 2023 | seekingalpha.comBiopharmaceuticals Contract Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)January 25, 2023 | finance.yahoo.comWell-Fed Analysts Stay Mum on Keryx Biopharma's Slow Drug LaunchSeptember 15, 2022 | thestreet.comKeryx (KERX) Q1 Loss Wider than Expected, Revenues BeatOctober 26, 2021 | finance.yahoo.comTwitter tests notification banner for suspended and locked accountsJuly 29, 2021 | au.finance.yahoo.comJoey Jordison, Slipknot co-founder and longtime drummer, dies at age 46July 29, 2021 | yahoo.comWhy Starbucks (SBUX) Might Surprise This Earnings SeasonJuly 28, 2021 | uk.finance.yahoo.comUN: World leaders can attend annual UN meeting in personJuly 27, 2021 | uk.finance.yahoo.comCreekstone Farms Meats Sizzle on Yoder Smokers With New PartnershipJuly 27, 2021 | nz.finance.yahoo.comMidtown, Atlanta Based Innovien Solutions Continues Growth StreakJuly 27, 2021 | au.finance.yahoo.comJill Biden Made This Versatile Bag Sell Out, and She Just Wore It AgainJuly 27, 2021 | nz.finance.yahoo.comIt's Your Business | More improvements on tap for Target on North ProspectJuly 27, 2021 | yahoo.com Get Keryx Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for KERX and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] KERX Media Mentions By Week KERX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KERX News Sentiment▼0.000.46▲Average Medical News Sentiment KERX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KERX Articles This Week▼00▲KERX Articles Average Week Get Keryx Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for KERX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novavax News Innoviva News OPKO Health News Ironwood Pharmaceuticals News Emergent BioSolutions News Rigel Pharmaceuticals News Sangamo Therapeutics News Codexis News XOMA News Vanda Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KERX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keryx Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Keryx Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KERX Stock Alerts